Forian Inc. Reports Significant Growth in Second Quarter 2025 Financial Results
Forian Inc. showcases a remarkable turnaround with a 56% increase in revenue and a net income of $0.2 million in Q2 2025, signaling strong market performance and operational efficiency.
Forian Inc., a leader in data science-driven information and analytics solutions for the life science, healthcare, and financial services sectors, has announced its financial results for the second quarter of 2025, revealing a significant improvement in both revenue and net income. The company reported a revenue of $7.5 million, marking a 56% increase from the $4.8 million recorded in the same period last year. This growth is attributed to strategic contract renewals, new client acquisitions, and the expansion of core capabilities.
Net income for the quarter stood at $0.2 million, or $0.01 per share, a substantial recovery from a net loss of $2.6 million, or $0.08 per share, in the second quarter of 2024. Adjusted EBITDA also saw a dramatic rise to $0.6 million, compared to $0.1 million in the prior year, underscoring the company's enhanced operational efficiency and profitability.
Max Wygod, CEO and Executive Chairman of Forian, highlighted the company's continued execution and growth trajectory, emphasizing the focus on both organic and strategic investments to strengthen the platform and deliver enhanced value across the healthcare ecosystem. The company's cash, cash equivalents, and marketable securities totaled $35.6 million as of June 30, 2025, providing a solid foundation for future growth and investment.
Forian has reconfirmed its full-year 2025 outlook, expecting revenue to be in the range of $28 to $30 million and Adjusted EBITDA between ($1.0) to $1.0 million. This optimistic forecast reflects the company's confidence in its business model and market position.
Investors and interested parties can access more information and register for the upcoming conference call discussing these results at www.forian.com/investors. The webcast will be available live at edge.media-server.com/mmc/p/76de8mny.
Forian's performance in the second quarter of 2025 demonstrates its ability to navigate the competitive landscape effectively, leveraging its data science and analytics expertise to drive growth and profitability. The company's strategic initiatives and financial discipline are expected to continue fueling its success in the evolving healthcare and life sciences markets.